Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (Q40115981)

17 September 2017

Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation (English)

1 reference

17 September 2017

0 references

12

1 reference

17 September 2017

F M Mattes

1

1 reference

17 September 2017

A Vargas

2

1 reference

17 September 2017

J Kopycinski

3

1 reference

17 September 2017

E G Hainsworth

4

1 reference

17 September 2017

P Sweny

5

1 reference

17 September 2017

G Nebbia

6

1 reference

17 September 2017

A Bazeos

7

1 reference

17 September 2017

M Lowdell

8

1 reference

17 September 2017

P Klenerman

9

1 reference

17 September 2017

R E Phillips

10

1 reference

17 September 2017

P D Griffiths

11

1 reference

17 September 2017

language of work or name

English

0 references

publication date

4 March 2008

1 reference

American Journal of Transplantation

17 September 2017

1 reference

17 September 2017

8

1 reference

17 September 2017

990-999

1 reference

17 September 2017

5

1 reference

Infection in organ-transplant recipients

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Prophylaxis for CMV should not now replace pre-emptive therapy in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

The case for cytomegalovirus prophylaxis in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Prophylaxis for CMV should now replace pre-emptive therapy in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

The dynamics of human cytomegalovirus replication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Dynamics of Cytomegalovirus Replication during Preemptive Therapy with Oral Ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Repertoire, diversity, and differentiation of specific CD8 T cells are associated with immune protection against human cytomegalovirus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Population analysis of antiviral T cell responses using MHC class I-peptide tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

The T cell response to persistent herpes virus infections in common variable immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Phenotypic analysis of antigen-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Interleukin-2 reconstitutes defective human immunodeficiency virus (HIV), and cytomegalovirus (CMV) specific CD8+ T cell proliferation in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Reinvigorating exhausted HIV-specific T cells via PD-1-PD-1 ligand blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Restoring function in exhausted CD8 T cells during chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Programmed death-1 expression in liver transplant recipients as a prognostic indicator of cytomegalovirus disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

T-cell dysregulation caused by chronic antigenic stress: the role of CMV in immunosenescence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Does memory improve with age? CD85j (ILT-2/LIR-1) expression on CD8 T cells correlates with 'memory inflation' in human cytomegalovirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Human Cytomegalovirus (HCMV) Replication Dynamics in HCMV‐Naive and ‐Experienced Immunocompromised Hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

Cytomegalovirus‐Specific Cellular Immune Responses and Viremia in Recipients of Allogeneic Stem Cell Transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2008.02191.X

10.1111/J.1600-6143.2008.02191.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference